The short version
Henry Meds is a GLP-1-shaped business. The product is a prescription for a GLP-1 receptor agonist — semaglutide, tirzepatide, or compounded variants — wrapped in a telehealth intake and a monthly subscription. The use case is weight management, and the experience is built tightly around it.
Boswell is a peptide-therapy platform. The compound menu is wider — BPC-157 for tissue repair, sermorelin for sleep, PT-141 for sexual health, NAD+ for energy, plus body-composition compounds like AOD-9604 and MOTS-C. Members come in already pointed at a goal or a compound, and a U.S.-licensed prescriber decides whether to prescribe.
| Topic | Henry Meds | Boswell |
|---|---|---|
| Primary product | GLP-1 weight-loss medications via telehealth | Peptide therapy via licensed providers + 503A compounding |
| Core use case | Weight management | Recovery, longevity, sleep, sexual health, skin, body composition |
| Starting point | Intake + eligibility, then a GLP-1 prescription | Goals review, provider intake, then a prescribed protocol |
| Compound menu | GLP-1 receptor agonists (semaglutide, tirzepatide variants) | Full peptide menu (BPC-157, TB-500, CJC-1295 + Ipa, NAD+, PT-141, GHK-Cu, MOTS-C, AOD-9604, Sermorelin, Glutathione) |
| Pricing model | Monthly subscription with medication included | Per-protocol pricing, prescription-required |
| Best fit | You want a GLP-1 prescription for weight management | You want a specific peptide protocol with provider oversight |
Different jobs to be done
Henry Meds is structured around can I get a GLP-1 prescribed and shipped predictably each month? The single product axis is weight loss, and the service is optimized for that journey: eligibility check, prescription, refills. Most members never need anything else from the platform.
Boswell is structured around can I get this specific peptide prescribed by a U.S.-licensed physician and compounded properly? The questions are different — recovery from a sports injury, sleep architecture, sexual function, cellular energy, skin and tissue repair. The compounds are different too. Boswell does have metabolic peptides in its menu, but the platform is intentionally broader than weight loss.
GLP-1s are a focused tool for a focused job. Peptide therapy is a wider menu — choose the one that matches your question.
When Henry Meds makes sense
Henry Meds earns its place when GLP-1 weight management is the goal and you want a service that's optimized for exactly that pathway. The intake, the eligibility flow, the medication delivery, and the price all work better when the platform isn't trying to be everything to everyone. If your physician has discussed GLP-1s and you'd rather pursue them via telehealth, that's the product fit.
It's also a reasonable choice if you have no plans to explore other peptide protocols and you'd prefer a single-purpose, single-medication membership.
When Boswell makes sense
Boswell earns its place when your interest extends beyond GLP-1s — or sits to the side of them entirely. You want BPC-157 for a tendon. You're curious about CJC-1295 + Ipamorelin for sleep and recovery. You want a PT-141 protocol prescribed by a real physician. You want NAD+ for energy without going through a research-chemicals vendor.
The value is access to a wider peptide menu under a U.S.-licensed prescriber, compounded by a 503A pharmacy, with refill oversight and proper labeling. Pricing is per-protocol, so you're paying for the medication itself rather than a single-product subscription. If you want a GLP-1 specifically, Henry Meds will probably be the more focused option. If you want any other peptide, this is the right address.
Questions worth asking before either
- Is my goal weight management specifically, or a broader peptide question?
- Have I discussed GLP-1 use with a primary care provider before adding telehealth into the loop?
- Is the prescriber a U.S.-licensed physician, and is the pharmacy a 503A compounding pharmacy?
- What does long-term follow-up look like — refill oversight, labs, off-ramping?
- Am I likely to want other peptide protocols within the next 12 months?
Sources